AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...

The interim phase 2 trial results show a good immune response in participants and the therapy is well tolerated to date.

The 78-year-old broadcaster lifted the lid on how he has been coping with the health news, as well as sharing his opinion on ...

What the Trained Eye Cannot See: Detecting Movement Defects in Early ... in Parkinson's symptoms over ... Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28 ...

Dexys Midnight Runners founding member Andy Leek has died aged 66 after a battle with Parkinson's disease. He died on ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...

Scientists stated that olfactory dysfunction occurs early in the development of some medical conditions: “Olfactory loss ...

(AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that AB-1003 (also known as LION-101) has received rare pediatric disease ...

“There’s really no definitive test in life to know whether someone has Parkinson’s disease. And so that really leads to a lot of uncertainty, but it also misdiagnosis unfortunately,” said Laurie H.

Research examined medical records from over one million people to uncover early indicators of the incurable condition.

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...